The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Williamson Robert F Iii since 2011.
This trader's CIK number is 1397331.
At the time of last reporting, Williamson Robert F Iii was the Officer of Perspective Therapeutics, Inc.. (stock ticker symbol CATX).
Also see all insider trading activities at Perspective Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2011 | VRUS | 0 | $0 | 31,666 | $3,304,600 | 20,000 | $60,000 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | CATX | 376,347 | $294,857 | 0 | $0 | 0 | $0 |
| 2023 | CATX | 27,343 | $8,178 | 0 | $0 | 0 | $0 |
2. Perspective Therapeutics, Inc. (CATX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2011-05-06 | VRUS | Sale | 31,666 | 104.36 | 3,304,600 |
| 2011-05-06 | VRUS | Option Ex | 20,000 | 3.00 | 60,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-11-25 | CATX | Buy | 6,266 | 3.65 | 22,839 |
| 2024-05-31 | CATX | Buy | 55,000 | 1.38 | 75,900 |
| 2024-01-30 | CATX | Buy | 127,206 | .71 | 90,316 |
| 2024-01-29 | CATX | Buy | 25,266 | .64 | 16,170 |
| 2024-01-26 | CATX | Buy | 110,613 | .58 | 64,155 |
| 2024-01-24 | CATX | Buy | 29,862 | .49 | 14,632 |
| 2024-01-25 | CATX | Buy | 22,134 | .49 | 10,845 |
| 2023-12-21 | CATX | Buy | 3,663 | .33 | 1,201 |
| 2023-12-18 | CATX | Buy | 10,000 | .26 | 2,600 |
| 2023-12-19 | CATX | Buy | 13,680 | .32 | 4,377 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Williamson Robert F Iii (Officer of Perspective Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.